Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Identifying genomic subtypes of pancreatic cancer from histology slides using AI-based tool

Identifying genomic subtypes of pancreatic cancer from histology slides using AI-based tool

Common antidepressant drugs help the immune system to attack tumors in mice

Common antidepressant drugs help the immune system to attack tumors in mice

Researchers clarify cellular processes related to radiation resistance of pancreatic cancer cells

Researchers clarify cellular processes related to radiation resistance of pancreatic cancer cells

Study elucidates the use of anticoagulants to treat bleeding in patients with gastrointestinal cancers

Study elucidates the use of anticoagulants to treat bleeding in patients with gastrointestinal cancers

Depleting SIRPα-deficient in macrophages activate tumor antigen-specific cytotoxic T cells

Depleting SIRPα-deficient in macrophages activate tumor antigen-specific cytotoxic T cells

Odor-based test could serve as a non-invasive approach to screen for harder-to-detect cancers

Odor-based test could serve as a non-invasive approach to screen for harder-to-detect cancers

Researchers are developing first prognostic, therapeutic epigenetic biomarker for pancreatic cancer patients

Researchers are developing first prognostic, therapeutic epigenetic biomarker for pancreatic cancer patients

UNSW researchers find novel way to attack the 'fortress' surrounding pancreatic tumors

UNSW researchers find novel way to attack the 'fortress' surrounding pancreatic tumors

Groundbreaking study optimizes patient's own immune system to fight tumors

Groundbreaking study optimizes patient's own immune system to fight tumors

Minorities substantially underrepresented in pancreatic cancer clinical trials

Minorities substantially underrepresented in pancreatic cancer clinical trials

New study finds a stark decrease in the number of abdominal surgeries among older adults

New study finds a stark decrease in the number of abdominal surgeries among older adults

Targeted therapies could exploit unique metabolic features of pancreatic cancer cells

Targeted therapies could exploit unique metabolic features of pancreatic cancer cells

Researchers develop new technology to reduce high error rates in gene sequencing

Researchers develop new technology to reduce high error rates in gene sequencing

Pancreatic cancer cells de-differentiate to spawn highly aggressive tumors, study shows

Pancreatic cancer cells de-differentiate to spawn highly aggressive tumors, study shows

Researchers develop first 3D organoid models of the pancreas from human stem cells

Researchers develop first 3D organoid models of the pancreas from human stem cells

Study sheds new light on the ability of pancreatic cancer cells to metastasize

Study sheds new light on the ability of pancreatic cancer cells to metastasize

COVID-19 deadlier than cars for over 40s, study finds

COVID-19 deadlier than cars for over 40s, study finds

Experts to discuss advanced cancer cell and gene therapies at Summit 2021

Experts to discuss advanced cancer cell and gene therapies at Summit 2021

Breast cancer survivors with excess body weight at increased risk of developing second cancer

Breast cancer survivors with excess body weight at increased risk of developing second cancer

CD40 drug before surgery can benefit patients with early-stage pancreatic cancer

CD40 drug before surgery can benefit patients with early-stage pancreatic cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.